Clinical trial
Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
NCT03862248 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- September 30, 2019
- Completion date
- October 1, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.